150 related articles for article (PubMed ID: 12148855)
1. The association between glutathione S-transferase P1 genotype and plasma level in head and neck cancer.
Kelders WP; Oude Ophuis MB; Roelofs HM; Peters WH; Manni JJ
Laryngoscope; 2002 Mar; 112(3):462-6. PubMed ID: 12148855
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the glutathione S-transferase P1 gene and head and neck cancer susceptibility.
Oude Ophuis MB; Roelofs HM; van den Brandt PA; Peters WH; Manni JJ
Head Neck; 2003 Jan; 25(1):37-43. PubMed ID: 12478542
[TBL] [Abstract][Full Text] [Related]
3. Plasma glutathione S-transferase P1-1 levels in patients with head and neck squamous cell carcinoma.
Oude Ophuis MB; Mulder TP; Peters WH; Manni JJ
Cancer; 1998 Jun; 82(12):2434-8. PubMed ID: 9635537
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer.
Oude Ophuis MB; Manni JJ; Peters WH
Acta Otolaryngol; 2006 Mar; 126(3):311-7. PubMed ID: 16618661
[TBL] [Abstract][Full Text] [Related]
7. Genotype and phenotype of glutathione-S-transferase in patients with head and neck carcinoma.
Konig-Greger D; Riechelmann H; Wittich U; Gronau S
Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15195058
[TBL] [Abstract][Full Text] [Related]
8. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
9. GST profiling may be useful in the screening for thyroid nodule malignancy.
Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
Cancer Lett; 2004 Jun; 209(2):129-37. PubMed ID: 15159014
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
11. Plasma glutathione S-transferase pi 1-1 AND alpha 1-1 levels in patients with bladder cancer.
Berendsen CL; Mulder TP; Peters WH
J Urol; 2000 Dec; 164(6):2126-8. PubMed ID: 11061940
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC).
Mutallip M; Nohata N; Hanazawa T; Kikkawa N; Horiguchi S; Fujimura L; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Mol Med; 2011 Mar; 27(3):345-52. PubMed ID: 21181092
[TBL] [Abstract][Full Text] [Related]
13. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistologic and molecular genetic studies of the effect of glutathione-S-transferases on the development of squamous epithelial carcinomas in the area of the head-neck].
Matthias C; Jahnke V; Hand P; Fryer AA; Strange RC
Laryngorhinootologie; 1999 Apr; 78(4):182-8. PubMed ID: 10407823
[TBL] [Abstract][Full Text] [Related]
19. An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma.
Miller DP; Asomaning K; Liu G; Wain JC; Lynch TJ; Neuberg D; Su L; Christiani DC
Cancer; 2006 Oct; 107(7):1570-7. PubMed ID: 16933328
[TBL] [Abstract][Full Text] [Related]
20. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
